Endo to pay $830M to settle pelvic mesh lawsuits

May 1, 2014

Drug and medical device maker Endo International says it will pay $830 million to resolve roughly 20,000 personal lawsuits from patients who say they were injured by the company's vaginal mesh implants.

The Irish company said in a statement Wednesday that the settlement is subject to a number of conditions and is not an admission of liability.

Tens of thousands of have sued Endo and other device makers over mesh used to repair pelvic collapse in women. Mesh implants were initially pitched to doctors as an improvement over surgery, but the Food and Drug Administration has concluded they carry a higher risk of side effects including pain, and infection.

On Tuesday, the FDA proposed regulating vaginal mesh repair products as "high-risk" medical devices, subject to stricter safety requirements.

Related Stories

Advocacy group seeks ban on pelvic surgical mesh

August 25, 2011

(AP) -- A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks.

Mesh doesn't up cure rate for vaginal prolapse repair

September 12, 2013

(HealthDay)—There are no differences in cure rates after three years of follow-up between women receiving mesh or no mesh for vaginal prolapse repair, according to a study published online Sept. 6 in Obstetrics & Gynecology.

Endo Health to pay $192.7M in gov't settlement

February 22, 2014

Endo Health will pay almost $193 million to resolve claims that it improperly marketed the shingles treatment Lidoderm for unapproved uses like treating lower back pain.

FDA wants stricter safety rules for pelvic mesh

April 29, 2014

Makers of trouble-prone implants used to surgically repair women's pelvic problems would be subject to stricter safety requirements under a federal proposal issued Tuesday.

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.